Emel Yaman
- Genetics top 10%
- Glioma Diagnosis and Treatment 5
-
- Cancer Treatment and Pharmacology 6
- Lung Cancer Research Studies 4
- Pancreatic and Hepatic Oncology Research 3
- Otorhinolaryngology top 10%
-
- Lung Cancer Treatments and Mutations 5
- Brain Metastases and Treatment 4
- Lung Cancer Diagnosis and Treatment 3
-
- Breast Cancer Treatment Studies 4
- Co-authors
- Mustafa BeneklıSüleyman BuyukberberBanu ÖztürkUğur ÇoşkunRamazan YıldızAli KayaMüge AkmansuBanu Sancak
- Cited by
- GeneticsOncologyOtorhinolaryngology
- Journals
- International Immunopharmacology (2 papers)Acta Neurochirurgica (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- TürkiyeUnited KingdomGermany
In The Last Decade
Emel Yaman
38 papers receiving 407 citations
Peers
Comparison fields: 5 of 61
- Genetics 88
- Oncology 160
- Otorhinolaryngology 23
- Pulmonary and Respiratory Medicine 131
- Cancer Research 56
Countries citing papers authored by Emel Yaman
This map shows the geographic impact of Emel Yaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emel Yaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emel Yaman more than expected).
Fields of papers citing papers by Emel Yaman
This network shows the impact of papers produced by Emel Yaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emel Yaman. The network helps show where Emel Yaman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emel Yaman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 2 | |
| 2 | 2015 | 8 | |
| 3 | 2013 | 4 | |
| 4 | 2010 | 2 | |
| 5 | 2010 | 6 | |
| 6 | 2010 | 27 | |
| 7 | 2010 | 2 | |
| 8 | 2010 | 9 | |
| 9 | Uterine Leiomyosarcoma Presenting with Neurological Symptoms: Differential Diagnosis | 2009 | 0 |
| 10 | 2009 | 4 | |
| 11 | 2009 | 10 | |
| 12 | 2009 | 13 | |
| 13 | 2009 | 36 | |
| 14 | 2008 | 5 | |
| 15 | 2008 | 8 | |
| 16 | 2008 | 19 | |
| 17 | 2008 | 18 | |
| 18 | 2008 | 7 | |
| 19 | 2008 | 7 | |
| 20 | 2007 | 7 |
About Emel Yaman
Emel Yaman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Dermatology, having authored 41 papers that have together received 419 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Glioma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Brain Metastases and Treatment (4 papers), Lung Cancer Research Studies (4 papers), Breast Cancer Treatment Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (88 citations), Oncology (160 citations) and Otorhinolaryngology (23 citations). Emel Yaman has collaborated with scholars based in Türkiye, United Kingdom and Germany. Frequent co-authors include Mustafa Beneklı, Süleyman Buyukberber, Banu Öztürk, Uğur Çoşkun, Ramazan Yıldız, Ali Kaya, Müge Akmansu, Banu Sancak, Aytuğ Üner and Özge Petek Erpolat. Their work appears in journals such as International Immunopharmacology, Acta Neurochirurgica and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.